Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IOVA · NASDAQ · Biological Products, (No Diagnostic Substances)
$6.90−0.41 (−5.61%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Iovance Biotherapeutics (IOVA) · oqro.io/stocks/IOVA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed a new position in IOVA for Q3 2026SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC no longer reported IOVA for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Hood River Capital Management LLC no longer reported IOVA for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 6, 2025
Perceptive Advisors LLC disclosed a reduced position in IOVA for Q1 2025SourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Officer purchased ~$55K of IOVA shares in the open marketSourceInsider trade · Traded May 23, 2025 · Filed May 27, 2025
Officer purchased ~$9.7K of IOVA shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 23, 2025
Siren, L.L.C. no longer reported IOVA for Q1 2025SourceInsider trade · Traded May 14, 2025 · Filed May 16, 2025
CEO purchased ~$42K of IOVA shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Avoro Capital Advisors LLC no longer reported IOVA for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a reduced position in IOVA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Avoro Capital Advisors LLC disclosed a reduced position in IOVA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Hood River Capital Management LLC disclosed an increased position in IOVA for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Perceptive Advisors LLC disclosed an increased position in IOVA for Q3 2024SourceInsider trade · Traded Nov 12, 2024 · Filed Nov 14, 2024
Director sold ~$503K of IOVA shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Hood River Capital Management LLC disclosed an increased position in IOVA for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Avoro Capital Advisors LLC disclosed a reduced position in IOVA for Q3 2024Fund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Hood River Capital Management LLC disclosed an increased position in IOVA for Q1 2025Source